ALS/ILS MEDICATION
- TRADE NAME
Phenergan
- Therapeutic Effects
- Antiemetic
- Antihistaminic
- anticholinergic
- sedative
- Indications (EMS)
- Nausea associated with
narcotic administration.
- Contraindications
- hypersensitivity
- newborn and premature infants
- nursing mothers
- CNS depression
- jaundice
- acutely ill or dehydrated children
- Precautions
- glaucoma
- asthma
- elderly patients
- pregnancy
- bone marrow depression
- Dosage
- EMT-I must have on-line medical control order prior to administration.
- 12.5 mg/slow IV or deep IM push over 1 minute.
- DO NOT REPEAT WITHOUT ON-LINE MED CONTROL ORDER.
- Route
- Side Effects
- sedation
- thickening of mucous
- drowsiness
- dizziness
- dry mouth
-
Toxic Effects
- CNS DEPRESSION
- CNS STIMULATION
- WANDERING PACEMAKER
- PROLONGED QT INTERVAL
- ST-T WAVE CHANGES
THIS HAS BEEN APPROVED
BY DR. NEELY AND DR. HEYNEKAMP
YOU MUST HAVE UPDATES ON
NEW MEDICATIONS PRIOR TO PLACING ON UNITS AND USE.